<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about AEZS</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Tue, 21 May 2013 03:54:53 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=AEZS" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/disappointing-1q-earnings-for-iart-analyst-blog-cm245205">
      <guid isPermaLink="false">245205</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SdU7zUn7pxA/disappointing-1q-earnings-for-iart-analyst-blog-cm245205</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Earnings</category>
      <category>Stocks</category>
      <title>Disappointing 1Q Earnings for IART - Analyst Blog</title>
      <description>Integra LifeSciences Holdings Corp.  (  IART  ) reported adjusted earnings per share (EPS) of 39 cents in the first quarter of 2013, declining 45.1% from the year-ago quarter, as well as below&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/SdU7zUn7pxA" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 10 May 2013 19:08:01 Z</pubDate>
      <a10:updated>2013-05-10T16:28:23Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AEZS</nasdaq:tickers>
      <nasdaq:tickers>ANIK</nasdaq:tickers>
      <nasdaq:tickers>ATHX</nasdaq:tickers>
      <nasdaq:tickers>EPS</nasdaq:tickers>
      <nasdaq:tickers>IART</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/disappointing-1q-earnings-for-iart-analyst-blog-cm245205</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/aeterna-zentarisergomed-join-forces-analyst-blog-cm236126">
      <guid isPermaLink="false">236126</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OY3qky3VFsg/aeterna-zentarisergomed-join-forces-analyst-blog-cm236126</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Aeterna Zentaris/Ergomed Join Forces - Analyst Blog</title>
      <description>Recently  Aeterna Zentaris Inc.  (  AEZS  ) announced that it has entered into an agreement with Ergomed Clinical Research Ltd. for co-developing AEZS-108 (doxorubicin peptide conjugate) for&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/OY3qky3VFsg" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 12 Apr 2013 02:09:35 Z</pubDate>
      <a10:updated>2013-04-11T23:12:58Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AEZS</nasdaq:tickers>
      <nasdaq:tickers>ATHX</nasdaq:tickers>
      <nasdaq:tickers>JNJ</nasdaq:tickers>
      <nasdaq:tickers>SPA</nasdaq:tickers>
      <nasdaq:tickers>UCBJF</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/aeterna-zentarisergomed-join-forces-analyst-blog-cm236126</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/major-setback-for-aeterna-zentaris-analyst-blog-cm226509">
      <guid isPermaLink="false">226509</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k7QsGiGcc4A/major-setback-for-aeterna-zentaris-analyst-blog-cm226509</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Major Setback for Aeterna Zentaris - Analyst Blog</title>
      <description>Aeterna Zentaris Inc.  (  AEZS  ) recently received a setback when an independent Data Safety Monitoring Board (DSMB) recommended the discontinuation of a phase III study on its oncology&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/k7QsGiGcc4A" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 13 Mar 2013 03:13:03 Z</pubDate>
      <a10:updated>2013-03-13T00:12:38Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AEZS</nasdaq:tickers>
      <nasdaq:tickers>CYTK</nasdaq:tickers>
      <nasdaq:tickers>OSIR</nasdaq:tickers>
      <nasdaq:tickers>TKPYY</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/major-setback-for-aeterna-zentaris-analyst-blog-cm226509</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/4-biopharma-catalyst-trades-offering-good-upside-potential-cm216774">
      <guid isPermaLink="false">216774</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WSg60SGBnAo/4-biopharma-catalyst-trades-offering-good-upside-potential-cm216774</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <category>US Markets</category>
      <title>4 BioPharma Catalyst Trades Offering Good Upside Potential</title>
      <description>Submitted by  Scott Matusow  as part of our  contributors program  .   To begin this week, I list four bio-pharma companies I feel have significant catalyst trade upside potential. What exactly&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/WSg60SGBnAo" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 12 Feb 2013 19:28:51 Z</pubDate>
      <a10:updated>2013-02-12T15:16:32Z</a10:updated>
      <author>Trefis Team</author>
      <nasdaq:tickers>AEZS</nasdaq:tickers>
      <nasdaq:tickers>DVAX</nasdaq:tickers>
      <nasdaq:tickers>MRK</nasdaq:tickers>
      <nasdaq:tickers>POZN</nasdaq:tickers>
      <nasdaq:tickers>ZIOP</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/4-biopharma-catalyst-trades-offering-good-upside-potential-cm216774</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/vicals-loss-narrower-than-expected-analyst-blog-cm215711">
      <guid isPermaLink="false">215711</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sOTYbsCYCPs/vicals-loss-narrower-than-expected-analyst-blog-cm215711</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Vical's Loss Narrower than Expected - Analyst Blog</title>
      <description>Vical Inc.  (  VICL  ) suffered a net loss per share of 9 cents in the fourth quarter of 2012, narrower than the Zacks Consensus Estimate of a loss of 10 cents per share but flat year over&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/sOTYbsCYCPs" height="1" width="1"/&gt;</description>
      <pubDate>Sat, 09 Feb 2013 02:22:01 Z</pubDate>
      <a10:updated>2013-02-08T22:49:25Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AEZS</nasdaq:tickers>
      <nasdaq:tickers>ALPMY</nasdaq:tickers>
      <nasdaq:tickers>BMY</nasdaq:tickers>
      <nasdaq:tickers>VICL</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/vicals-loss-narrower-than-expected-analyst-blog-cm215711</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/zacks-rank-1-addition-for-friday-tale-of-the-tape-cm215444">
      <guid isPermaLink="false">215444</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EOrcHyv9pyg/zacks-rank-1-addition-for-friday-tale-of-the-tape-cm215444</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>Zacks Rank #1 Addition for Friday  - Tale of the Tape</title>
      <description>Here are 5 stocks added to the Zacks Rank #1 ("strong buy") List today:    AEterna Zentaris Inc.  (  AEZS  )   Alkermes Plc  (  ALKS  )   American Railcar Industries, Inc.  (  ARII  )&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/EOrcHyv9pyg" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 08 Feb 2013 18:44:01 Z</pubDate>
      <a10:updated>2013-02-08T15:54:18Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AETUF</nasdaq:tickers>
      <nasdaq:tickers>AEZS</nasdaq:tickers>
      <nasdaq:tickers>ALKS</nasdaq:tickers>
      <nasdaq:tickers>ARII</nasdaq:tickers>
      <nasdaq:tickers>AWI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/zacks-rank-1-addition-for-friday-tale-of-the-tape-cm215444</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/zacks-rank-1-addition-for-wednesday-tale-of-the-tape-cm214587">
      <guid isPermaLink="false">214587</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fDDmRioZ0BM/zacks-rank-1-addition-for-wednesday-tale-of-the-tape-cm214587</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>Zacks Rank #1 Addition for Wednesday  - Tale of the Tape</title>
      <description>Here are 5 stocks added to the Zacks Rank #1 ("strong buy") List  today:    AEterna Zentaris Inc.  (  AEZS  )   Agenus Inc.  (  AGEN  )   Alkermes Plc  (  ALKS  )   American Railcar&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/fDDmRioZ0BM" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 06 Feb 2013 18:44:01 Z</pubDate>
      <a10:updated>2013-02-06T14:53:56Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>ABCB</nasdaq:tickers>
      <nasdaq:tickers>AEZS</nasdaq:tickers>
      <nasdaq:tickers>AGEN</nasdaq:tickers>
      <nasdaq:tickers>ALKS</nasdaq:tickers>
      <nasdaq:tickers>ARII</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/zacks-rank-1-addition-for-wednesday-tale-of-the-tape-cm214587</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/zacks-rank-1-additions-for-friday-tale-of-the-tape-cm210871">
      <guid isPermaLink="false">210871</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OEi3YXv9L3c/zacks-rank-1-additions-for-friday-tale-of-the-tape-cm210871</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>Zacks Rank #1 Additions for Friday  - Tale of the Tape</title>
      <description>Here are 5 stocks added to the Zacks Rank #1 ("strong buy") List  today:    AEterna Zentaris Inc.  (  AEZS  )   Aircastle Limited  (  AYR  )   BASF SE (ADR)  (  BASFY  )   BioCryst&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/OEi3YXv9L3c" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 25 Jan 2013 18:44:01 Z</pubDate>
      <a10:updated>2013-01-25T15:21:37Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AEZS</nasdaq:tickers>
      <nasdaq:tickers>AYR</nasdaq:tickers>
      <nasdaq:tickers>BASFY</nasdaq:tickers>
      <nasdaq:tickers>BCRX</nasdaq:tickers>
      <nasdaq:tickers>CECE</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/zacks-rank-1-additions-for-friday-tale-of-the-tape-cm210871</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/zacks-rank-1-additions-for-friday-tale-of-the-tape-cm208798">
      <guid isPermaLink="false">208798</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PLnz9lHol3I/zacks-rank-1-additions-for-friday-tale-of-the-tape-cm208798</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>Zacks Rank #1 Additions for Friday  - Tale of the Tape</title>
      <description>Here are 5 stocks added to the Zacks Rank #1 ("strong buy") List  today:    AEterna Zentaris Inc.  (  AEZS  )   Agenus Inc.  (  AGEN  )   Alkermes Plc  (  ALKS  )   Allied Nevada Gold&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/PLnz9lHol3I" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 18 Jan 2013 18:44:01 Z</pubDate>
      <a10:updated>2013-01-18T15:18:03Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AEZS</nasdaq:tickers>
      <nasdaq:tickers>AGEN</nasdaq:tickers>
      <nasdaq:tickers>ALKS</nasdaq:tickers>
      <nasdaq:tickers>ALL</nasdaq:tickers>
      <nasdaq:tickers>ANV</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/zacks-rank-1-additions-for-friday-tale-of-the-tape-cm208798</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/amrn-aims-to-fortify-vascepa-patent-analyst-blog-cm208702">
      <guid isPermaLink="false">208702</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LGOzhRcclFM/amrn-aims-to-fortify-vascepa-patent-analyst-blog-cm208702</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>AMRN Aims to Fortify Vascepa Patent - Analyst Blog</title>
      <description>Amarin Corporation plc  (  AMRN  ), recently announced that the notice of patent allowance for US application serial number 13/610,217 has been published by the US Patent and Trademark Office&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/LGOzhRcclFM" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 18 Jan 2013 04:26:01 Z</pubDate>
      <a10:updated>2013-01-18T01:13:55Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AEZS</nasdaq:tickers>
      <nasdaq:tickers>AMRN</nasdaq:tickers>
      <nasdaq:tickers>TRGT</nasdaq:tickers>
      <nasdaq:tickers>VRX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/amrn-aims-to-fortify-vascepa-patent-analyst-blog-cm208702</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/loss-widens-at-irwd-on-higher-costs-analyst-blog-cm208130">
      <guid isPermaLink="false">208130</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yUHhXMhGXeA/loss-widens-at-irwd-on-higher-costs-analyst-blog-cm208130</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>Loss Widens at IRWD on Higher Costs - Analyst Blog</title>
      <description>Ironwood Pharmaceuticals, Inc.'s  (  IRWD  ) fourth-quarter 2012 loss of 41 cents per share compared unfavorably with the year-ago loss of 7 cents per share. Results were hurt by higher&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/yUHhXMhGXeA" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 16 Jan 2013 20:40:01 Z</pubDate>
      <a10:updated>2013-01-16T17:18:17Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AEZS</nasdaq:tickers>
      <nasdaq:tickers>FRX</nasdaq:tickers>
      <nasdaq:tickers>IRWD</nasdaq:tickers>
      <nasdaq:tickers>TRGT</nasdaq:tickers>
      <nasdaq:tickers>VRX</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/loss-widens-at-irwd-on-higher-costs-analyst-blog-cm208130</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-cm207582">
      <guid isPermaLink="false">207582</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7SA9OnFCdX0/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-cm207582</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>Zacks #1 Rank Additions for Tuesday  - Tale of the Tape</title>
      <description>Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List today:    AEterna Zentaris Inc.  (  AEZS  )   Alkermes Plc  (  ALKS  )   Amyris Inc.  (  AMRS  )   Aqua America Inc.&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/7SA9OnFCdX0" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 15 Jan 2013 18:44:01 Z</pubDate>
      <a10:updated>2013-01-15T15:18:16Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AEZS</nasdaq:tickers>
      <nasdaq:tickers>ALKS</nasdaq:tickers>
      <nasdaq:tickers>AMRS</nasdaq:tickers>
      <nasdaq:tickers>BGS</nasdaq:tickers>
      <nasdaq:tickers>WTR</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/zacks-1-rank-additions-for-tuesday-tale-of-the-tape-cm207582</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/spa-for-aeterna-zentaris-candidate-analyst-blog-cm203392">
      <guid isPermaLink="false">203392</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Dw_7G4DMUfE/spa-for-aeterna-zentaris-candidate-analyst-blog-cm203392</link>
      <category>Investing</category>
      <category>Business</category>
      <category>Stocks</category>
      <title>SPA for Aeterna Zentaris Candidate  - Analyst Blog</title>
      <description>Aeterna Zentaris Inc.  (  AEZS  ) recently announced that its oncology candidate, AEZS-108 (doxorubicin peptide conjugate) will be evaluated under US Food and Drug Administration's (FDA)&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Dw_7G4DMUfE" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 02 Jan 2013 19:30:01 Z</pubDate>
      <a10:updated>2013-01-02T16:03:05Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AEZS</nasdaq:tickers>
      <nasdaq:tickers>GALE</nasdaq:tickers>
      <nasdaq:tickers>SPA</nasdaq:tickers>
      <nasdaq:tickers>TRGT</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/spa-for-aeterna-zentaris-candidate-analyst-blog-cm203392</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/premarket-most-active-for-dec-28-2012-bac-nok-qqq-fb-aezs-rimm-f-c-aapl-siri-nxy-bp-cm202628">
      <guid isPermaLink="false">202628</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hq651jBhqXU/premarket-most-active-for-dec-28-2012-bac-nok-qqq-fb-aezs-rimm-f-c-aapl-siri-nxy-bp-cm202628</link>
      <category>News Headlines</category>
      <category>Pre-market Most Active</category>
      <title>Pre-Market Most Active for Dec 28, 2012 :  BAC, NOK, QQQ, FB, AEZS, RIMM, F, C, AAPL, SIRI, NXY, BP</title>
      <description>The  NASDAQ 100 Pre-Market Indicator  is down -7.18 to 2,625.76. The total Pre-Market volume is currently 4,463,460 shares traded.    The following are the   most active stocks for the pre-market&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Hq651jBhqXU" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 28 Dec 2012 18:39:47 Z</pubDate>
      <a10:updated>2012-12-28T14:00:34Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>AAPL</nasdaq:tickers>
      <nasdaq:tickers>AEZS</nasdaq:tickers>
      <nasdaq:tickers>BAC</nasdaq:tickers>
      <nasdaq:tickers>BP</nasdaq:tickers>
      <nasdaq:tickers>C</nasdaq:tickers>
      <nasdaq:tickers>F</nasdaq:tickers>
      <nasdaq:tickers>FB</nasdaq:tickers>
      <nasdaq:tickers>NOK</nasdaq:tickers>
      <nasdaq:tickers>NXY</nasdaq:tickers>
      <nasdaq:tickers>QQQ</nasdaq:tickers>
      <nasdaq:tickers>RIMM</nasdaq:tickers>
      <nasdaq:tickers>SIRI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/premarket-most-active-for-dec-28-2012-bac-nok-qqq-fb-aezs-rimm-f-c-aapl-siri-nxy-bp-cm202628</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/zacks-1-rank-additions-for-monday-tale-of-the-tape-cm187080">
      <guid isPermaLink="false">187080</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tnse3gNzTs4/zacks-1-rank-additions-for-monday-tale-of-the-tape-cm187080</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <category>Stocks</category>
      <title>Zacks #1 Rank Additions for Monday  - Tale of the Tape</title>
      <description>Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List today:    AEterna Zentaris Inc.  (  AEZS  )   Agrium Inc.  (  AGU  )   Avery Dennison Corp.  (  AVY  )   Bemis&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/tnse3gNzTs4" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 05 Nov 2012 18:14:01 Z</pubDate>
      <a10:updated>2012-11-05T15:39:37Z</a10:updated>
      <author>Zacks Equity Research</author>
      <nasdaq:tickers>AEZS</nasdaq:tickers>
      <nasdaq:tickers>AGU</nasdaq:tickers>
      <nasdaq:tickers>AVY</nasdaq:tickers>
      <nasdaq:tickers>BCOR</nasdaq:tickers>
      <nasdaq:tickers>BMS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/zacks-1-rank-additions-for-monday-tale-of-the-tape-cm187080</feedburner:origLink></item>
  </channel>
</rss>
